• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由β-内酰胺类抗生素筛选出的阴沟肠杆菌多重耐药突变体。

Multiply resistant mutants of Enterobacter cloacae selected by beta-lactam antibiotics.

作者信息

Then R L, Angehrn P

出版信息

Antimicrob Agents Chemother. 1986 Nov;30(5):684-8. doi: 10.1128/AAC.30.5.684.

DOI:10.1128/AAC.30.5.684
PMID:3492174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176514/
Abstract

Mutants of Enterobacter cloacae, selected in vitro with ceftriaxone, ceftazidime, carumonam, or aztreonam, fell into several distinct classes. Three mutants highly resistant to nearly all beta-lactam antibiotics were stably derepressed for beta-lactamase production. Although no other changes could be detected, virulence in a mouse septicemia model was decreased in two of these mutants. One mutant, 908-Ssi, showed selectively decreased susceptibility to ampicillin and cefotetan. A change in beta-lactamase expression was thought to be responsible for this. Alterations in the production of two outer membrane proteins with molecular sizes of 36.5 and 39 kilodaltons were responsible for multiple antibiotic resistance in two mutants, both of which acquired a low level of resistance to beta-lactam antibiotics. Whereas one of the mutants, AMA-R, simultaneously acquired resistance to chloramphenicol and trimethoprim, the other, AZT-R, became hypersusceptible to these and other hydrophobic agents. Both strains had drastically reduced virulence in mice.

摘要

用头孢曲松、头孢他啶、卡芦莫南或氨曲南在体外筛选出的阴沟肠杆菌突变体可分为几个不同的类别。三个对几乎所有β-内酰胺类抗生素高度耐药的突变体,其β-内酰胺酶的产生处于稳定的去阻遏状态。尽管未检测到其他变化,但其中两个突变体在小鼠败血症模型中的毒力有所下降。一个突变体908-Ssi对氨苄西林和头孢替坦的敏感性选择性降低。据认为,β-内酰胺酶表达的变化是造成这种情况的原因。两个分子大小分别为36.5和39千道尔顿的外膜蛋白产量的改变导致了两个突变体的多重耐药性,这两个突变体均获得了对β-内酰胺类抗生素的低水平耐药性。其中一个突变体AMA-R同时获得了对氯霉素和甲氧苄啶的耐药性,另一个突变体AZT-R则对这些及其他疏水性药物变得高度敏感。这两种菌株在小鼠中的毒力均大幅降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9d3/176514/6677ba9677dd/aac00166-0083-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9d3/176514/6677ba9677dd/aac00166-0083-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9d3/176514/6677ba9677dd/aac00166-0083-a.jpg

相似文献

1
Multiply resistant mutants of Enterobacter cloacae selected by beta-lactam antibiotics.由β-内酰胺类抗生素筛选出的阴沟肠杆菌多重耐药突变体。
Antimicrob Agents Chemother. 1986 Nov;30(5):684-8. doi: 10.1128/AAC.30.5.684.
2
Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.克服阴沟肠杆菌中头孢菌素酶介导的β-内酰胺耐药性的方法。
Chemioterapia. 1985 Feb;4(1):83-9.
3
Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
J Antimicrob Chemother. 1991 Dec;28(6):791-800. doi: 10.1093/jac/28.6.791.
4
Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae.β-内酰胺酶和外膜蛋白在阴沟肠杆菌多重β-内酰胺耐药中的作用
Antimicrob Agents Chemother. 1985 Apr;27(4):455-9. doi: 10.1128/AAC.27.4.455.
5
Reduced expression of outer-membrane proteins in beta-lactam-resistant mutants of Enterobacter cloacae.阴沟肠杆菌β-内酰胺抗性突变体中外膜蛋白表达降低。
J Gen Microbiol. 1987 Dec;133(12):3383-92. doi: 10.1099/00221287-133-12-3383.
6
Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
Chemotherapy. 1992;38(2):82-91. doi: 10.1159/000238946.
7
Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.铜绿假单胞菌在使用新型β-内酰胺类抗生素治疗期间对β-内酰胺类抗生素产生耐药性。
Chemioterapia. 1985 Feb;4(1):95-101.
8
Targets of the beta-lactam antibiotics, penicillin-binding proteins, in ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae.β-内酰胺类抗生素的作用靶点,即青霉素结合蛋白,在耐氨苄西林、不产β-内酰胺酶的流感嗜血杆菌中的情况。
J Infect Dis. 1992 Jun;165 Suppl 1:S107-9. doi: 10.1093/infdis/165-supplement_1-s107.
9
Sch 29482: activity against susceptible and beta-lactam resistant variants of Enterobacteriaceae.Sch 29482:对肠杆菌科的敏感菌株及β-内酰胺耐药菌株的活性。
J Antimicrob Chemother. 1982 Feb;9 Suppl C:203-12. doi: 10.1093/jac/9.suppl_c.203.
10
Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae.β-内酰胺酶水解和外膜通透性对阴沟肠杆菌头孢曲松耐药性的作用
Antimicrob Agents Chemother. 1987 Oct;31(10):1589-95. doi: 10.1128/AAC.31.10.1589.

引用本文的文献

1
Prevalence, plasmids and antibiotic resistance correlation of enteric bacteria in different drinking water resources in sohag, egypt.埃及索哈杰不同饮用水源中肠道细菌的流行率、质粒与抗生素耐药性的相关性
Jundishapur J Microbiol. 2015 Jan 23;8(1):e18648. doi: 10.5812/jjm.18648. eCollection 2015 Jan.
2
Method for estimation of low outer membrane permeability to beta-lactam antibiotics.评估β-内酰胺类抗生素低外膜通透性的方法。
Antimicrob Agents Chemother. 2002 Sep;46(9):2901-7. doi: 10.1128/AAC.46.9.2901-2907.2002.
3
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon.

本文引用的文献

1
BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.BRL 17421是一种新型β-内酰胺抗生素,对β-内酰胺酶具有高度抗性,在人体内可产生高且持久的血清浓度。
Antimicrob Agents Chemother. 1981 Jul;20(1):38-46. doi: 10.1128/AAC.20.1.38.
2
Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.多种β-内酰胺类抗生素对阴沟肠杆菌β-内酰胺酶的诱导作用。
Antimicrob Agents Chemother. 1980 Sep;18(3):382-5. doi: 10.1128/AAC.18.3.382.
3
Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
染色体介导的多重抗生素耐药性调控:mar操纵子
Antimicrob Agents Chemother. 1997 Oct;41(10):2067-75. doi: 10.1128/AAC.41.10.2067.
4
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem.对耐亚胺培南产气肠杆菌所致医院感染的临床与细菌学研究
J Clin Microbiol. 1993 Jan;31(1):123-7. doi: 10.1128/jcm.31.1.123-127.1993.
5
Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli.大肠杆菌多重抗生素耐药性(mar)位点的遗传与功能分析
J Bacteriol. 1993 Mar;175(5):1484-92. doi: 10.1128/jb.175.5.1484-1492.1993.
6
The kinetics of non-stoichiometric bursts of beta-lactam hydrolysis catalysed by class C beta-lactamases.C类β-内酰胺酶催化的β-内酰胺水解非化学计量爆发动力学。
Biochem J. 1993 Oct 1;295 ( Pt 1)(Pt 1):295-304. doi: 10.1042/bj2950295.
7
Ability of newer beta-lactam antibiotics to induce beta-lactamase production in Enterobacter cloacae.新型β-内酰胺类抗生素诱导阴沟肠杆菌产生β-内酰胺酶的能力。
Eur J Clin Microbiol. 1987 Aug;6(4):451-5. doi: 10.1007/BF02013109.
8
Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness.甲型副伤寒沙门氏菌的突变通过降低通透性和侵袭性丧失赋予对几类抗生素的交叉耐药性。
Antimicrob Agents Chemother. 1988 Feb;32(2):195-201. doi: 10.1128/AAC.32.2.195.
9
Antibiotic uptake into gram-negative bacteria.抗生素进入革兰氏阴性菌的过程。
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):713-20. doi: 10.1007/BF01975036.
10
Outer membrane barrier as a mechanism of antimicrobial resistance.外膜屏障作为一种抗菌耐药机制。
Antimicrob Agents Chemother. 1989 Nov;33(11):1831-6. doi: 10.1128/AAC.33.11.1831.
阴沟肠杆菌和铜绿假单胞菌中的头孢菌素酶截留不可水解头孢菌素作为一种可能的耐药机制。
Antimicrob Agents Chemother. 1982 May;21(5):711-7. doi: 10.1128/AAC.21.5.711.
4
31P nuclear magnetic resonance and freeze-fracture electron microscopy studies on Escherichia coli. III. The outer membrane.大肠杆菌的31P核磁共振与冷冻断裂电子显微镜研究。III. 外膜
Biochim Biophys Acta. 1980 Apr 24;597(3):518-32. doi: 10.1016/0005-2736(80)90224-2.
5
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.新型广谱头孢菌素所选择的新型耐药性:一个值得关注的问题。
J Infect Dis. 1983 Mar;147(3):585-9. doi: 10.1093/infdis/147.3.585.
6
Chromosomal loci associated with antibiotic hypersensitivity in pulmonary isolates of Pseudomonas aeruginosa.
J Gen Microbiol. 1984 Apr;130(4):825-34. doi: 10.1099/00221287-130-4-825.
7
New Salmonella typhimurium mutants with altered outer membrane permeability.具有改变的外膜通透性的新型鼠伤寒沙门氏菌突变体。
J Bacteriol. 1984 Aug;159(2):704-12. doi: 10.1128/jb.159.2.704-712.1984.
8
Different mechanisms of resistance to latamoxef (moxalactam) in Serratia marcescens.
J Antimicrob Chemother. 1984 Jan;13(1):15-22. doi: 10.1093/jac/13.1.15.
9
Properties of brodimoprim as an inhibitor of dihydrofolate reductases.
Chemotherapy. 1984;30(1):18-25. doi: 10.1159/000238239.
10
Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.新型β-内酰胺类抗生素治疗期间耐药性的出现:诱导性β-内酰胺酶的作用及对未来的影响。
Rev Infect Dis. 1983 Jul-Aug;5(4):639-48. doi: 10.1093/clinids/5.4.639.